What We Look For?
- Kashiv BioSciences has a robust pipeline of biosimilar, complex peptide generic, 505(b)(2), and mRNA programs that
span from early development to advanced clinical stages. We are seeking commercialization partners for our internally
developed products globally through licensing, strategic partnering, or profit-sharing joint ventures at meaningful
development inflection points.
To continue expanding our biosimilars pipeline, we are also evaluating in-licensing opportunities for biosimilars that have completed analytical similarity testing with innovator-branded biologics for global development.